Trial intelligence / Profile preview

Carvedilol CR + Lisinopril in Hypertension

NCT00624065Phase 3Completed

Sponsor
GSK
Start
Mar 2008
Primary completion
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of carvedilol in essential hypertension, sponsored by GSK. Started Mar 2008; status: completed.

02

Drugs

carvedilol
03

Conditions

essential hypertension

Beyond the preview

Go deeper on NCT00624065.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00624065.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call